Rajan Saggar: Clinical Trials

2 trials sponsored by Rajan Saggar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 41Withdrawn 1

Follow Rajan Saggar: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
Treprostinil - Pulmonary Arterial Hypertension, Interstitial Lung Disease
Phase 2CompletedRajan Saggar152008-07-012020-09-09
Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
bosentan - Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis
Phase 4WithdrawnRajan Saggar2007-10-012018-03-06

Conditions studied

Idiopathic Pulmonary Fibrosis (2)  ·  Pulmonary Arterial Hypertension (2)  ·  Hypertension, Pulmonary (1)  ·  Lung Diseases, Interstitial (1)  ·  Pulmonary Fibrosis (1)

Interventions

Bosentan (1)  ·  treprostinil (1)

Countries

United States (2)

Top investigators

David Zisman, MD (1)

Results publications

PMID 24431095